Despite the improvements in the dose calculation models of the commercial treatment planning systems (TPS), their ability to accurately predict patient dose is still limited.
pendent patient dose validation system with an elaborate MLC model for more accurate dose evaluation. Varian Clinac 2300 IX was simulated using Geant4 toolkits, after which MC commissioning with measurements was performed to validate the simulation model. A DICOM-RT interface was developed to obtain the beam delivery conditions including the hundreds of MLC motions. Finally, the TPS dose distributions were compared with the MC dose distributions for water phantom cases and a patient case.
Our results show that the TPS overestimated the absolute abutting leakage dose in the closed MLC field, with about 20% more of the maximum dose than that of the MC calculation. For water phantom cases, the dose distributions inside the target region were almost identical with the dose difference of less than 2%, while the dose near the edge of the target shows difference about 10% between Geant4 and TPS due to geometrical differences in MLC model. For the patient analysis, the Geant4 and TPS doses of all organs were matched well within 1.4% of the prescribed dose. However, for organs located in areas with high ratio of leaf pairs with distances less than 10 mm leaf pair (LP (<10mm) ), the maximum dose of TPS was overestimated by about 3% of the prescribed dose. These dose comparison results demonstrate that our system for calculating the patient dose is quite accurate. Furthermore, if the MLC sequences in treatment plan have a large ratio of LP (short) , more than 3% dose difference in normal tissue could be seen.
| INTRODUCTION
Volumetric modulated arc therapy (VMAT) and intensity modulated radiotherapy (IMRT) are techniques for treating cancer that utilize highly conformal dose distributions generated by multileaf collimator (MLC) motion. The conformity and uncertainty in dose delivery of VMAT/IMRT are sensitive to the structural details of the MLC; thus, accurate MLC modeling is very important for successful patient treatment and for reducing side effects.
1 However, detailed modeling of the complex MLC geometry to reflect its precise dosimetric properties is challenging in commercial treatment planning systems (TPS). 2 Molineu et al. 3 reported the results of an analysis of a multiinstitutional IMRT clinical trial using the anthropomorphic head and neck IMRT phantom at the Radiological Physics Center. In this study 81.6% of the 1139 irradiations at 763 institutions passed the gamma analysis criteria of 7%/4 mm when the calculated and measured dose distributions were compared. The head and neck IMRT phantom was introduced in 2001 and 10 yr of data analysis showed that the phantom pass rate increased from 66% to 81.6%. Molineu et al. 3 reported that a key factor of the increment of the phantom pass rate is the improvement in the modeling of MLC leaves in TPS. Nevertheless, TPS still uses the MLC leaves with flat ends to simplify the dose calculations and compensates the rounded leaf transmission by shifting the leaf positions. 4 This shifting distance is called as a dosimetric leaf gap (DLG) and many trials have endeavored to find the optimal DLG, with the goal of minimizing uncertainty in the typical patient plan. [5] [6] [7] [8] [9] However, variations in leaf end shape cause the dosimetric effect to vary due to the irregular shape and size of the resulting fields; therefore, each dosimetric effect should be verified individually. 7 In the case of dynamic MLC, the dosimetric effect of the radiation transmitted and scattered from the rounded leaf ends can exceed 10% of the total dose. [10] [11] [12] Even a 1% improvement in dose delivery precision has been reported to increase the cure rate for early stage tumors by 2%. 13 Moreover, a 5% change in dose can result in 10-20% change in tumor control probability or up to 20-30% change in normal tissue complication rates if the prescribed dose falls along the steepest region of the dose-effect curve. computational human phantoms and simulation of DNA strand damage. 32, 33 In particular, Geant4 is able to handle dynamic geometry changes, which significantly facilitates true four-dimensional Monte Carlo simulations, for example, dynamic MLC motion, patient organs, rotating machine parts, and moving scanners. 34, 35 Although the calculation time of Geant4 is longer than that of EGSnrc/BEAMnrc, this obstacle could be overcome by increasing the computational power and implementing multithreading features.
The aim of this study was to develop an independent dose calculation system for VMAT/IMRT with an automated DICOM-RT interface and the linac head simulation using the Geant4 code. The window, flattening filter, ion chamber, mirror, jaws, and MLC were modeled in present work (Fig. 1) . The Varian Millennium MLC was modeled using the Geant4 (version 10.00.p01) G4Tubs, G4Box, and G4ExtrudedSolid classes. Each leaf includes support rail, tongue, and groove geometry designed by the G4SubtractionSolid class. Each leaf was divided into two major sections, a rounded edge and a body.
The rounded edge consisted of four solid shapes such as two quarter-circles, one subtracted sector of a circle, two trapezoids, and/or one box. These solids were used to design a complex geometrical figure. In contrast, the body section was modeled simply by the G4ExtrudedSolid class. Ultimately, these solids were independently positioned in one mother volume. The Varian Millennium MLC consists of 60 leaf pairs (LPs) which have three types of leaf: full, half, and outboard. Each leaf design is mirrored on the opposite side of the bank. We defined x mm distance between paired opposite leaf tips as LP (x mm) in this study. 
2.A.2 | Beam commissioning

2.B | Experimental validation of the modeled MLC
For evaluation of the modeled MLC, two kinds of film measurement were performed with a solid water phantom using a Varian Clinac 2300 IX instrument ( 
2.C | Development of the DICOM-RT interface
For MC simulations of radiotherapy plans, the automated DICOM-RT interface is essential due to many beam delivery parameters in the treatment plans. The DICOM files for radiotherapy planning consist of four file types: CT images, RT structures, RT plans, and RT doses.
These files have a format for storing information associated with a value representation (VR) that indicates the encoding type and a tag that uses 8-digit hexadecimal numbers. 40 To extract patient-dependent parameters, data can be discriminated using the DICOM tag while reading the file. The DICOM file reading process was benchmarked against the Geant4 example. A flow chart of the in-house patient dose validation system, including the automated DICOM-RT interface, is illustrated in Fig. 3 . In this system, DICOM files are created from the Eclipse ™ TPS for patient-specific VMAT/IMRT planning and the DICOM-RT interface extracts the patient-specific parameters needed for the Monte Carlo simulation from each file.
The dose validation system extracts dimension information from CT images and the HU value of each pixel and then models the geometry of the CT images using the G4PVReplica class. Next, material is assigned to each pixel with the HU to electron density (ED) Kim et al. 41 reported that Geant4-based MC dose distributions can be significantly affected by the material conversion method. Therefore, the Schneider material conversion method was used for patient cases. 42 If a special volume (e.g., the fiducial marker, virtual water phantom, and couch) is present in the CT image, EC and MD would be defined in the region of interest (ROI) based on the physical property value stored in RT structure file; this process was automated in our system. | 97 divided by the total MU. However, the number of particles for each control point is differently calculated between IMRT and VMAT. For IMRT simulations, the number of particles is zero for the first control point and the dose calculation starts from the second control point according to the MU weight. On the other hand, for VMAT simulation, only half MU weight for the first and end control points was applied to calculate the number of particles, otherwise, the average MU weight for the current and previous control points was applied.
IMRT/VMAT simulation was performed with electromagnetic process in G4EmStandardPhysics_option3.
Finally, the Geant4 dose distribution was compared with the TPS dose distribution using Computational Environment for Radiation
Research (CERR) software. 43 The CERR program allows users to handle DICOM files in Matlab and analyze dose distributions with dosevolume histograms (DVH) and 3D dose differences. 43 
2.D | Evaluation of VMAT/IMRT plans
The VMAT/IMRT plans calculated by the TPS (Eclipse ™ version 8.9) using the Analytical Anisotropic Algorithm (AAA) were compared with the plans calculated by the in-house patient dose validation system. In the VMAT/IMRT plan, the DLG value and the leaf transmission were determined to be 0.165 cm and 1.7%, respectively. In order to predict the absolute dose in a subject, a dose scaling factor (DSF) needed to be calculated because we cannot use the same amount of primary electrons as that used in the real treatment for the Geant4 simulation.
We determined the DSF by finding a relationship between the dose calculated by the TPS with 100 MU and the dose calculated by the Geant4 with 2 × 10 9 primary electrons in the water phantom. The reason for using 2 × 10 9 primary electrons in Geant4 to determine the DSF was that the statistical error of the dose distribution was less than 2% and it was small enough to decide the maximum dose in the water phantom. The dose distribution in the water phantom was calculated by using 10 × 10 cm 2 formed with only jaws. After that, the DSF was calculated by matching the maximum dose value in the central depth dose distributions calculated by the Geant4 to that calculated by the TPS. Whenever applying this DSF to the dose distribution of different treatment plan, the DSF should be divided by the ratio of the used number of primary electrons and 2 × . The dose differences between the GBD and Geant4
were evaluated for all range of distribution except for the steep dose fall-off region. The reason for this exception will be discussed in the next section. The PDD profiles calculated by the Geant4 matched well with the GBD. Specifically, the local differences of each other were within 1.5% for all field sizes. 39 The lateral dose profiles calculated by the Geant4 for all field sizes agreed with the GBD within 1.6% including the outer penumbra region. 39 The statistical fluctuations in computed dose distributions were about ±0.6%. The calculations were performed on two Intel Xeon E5-2697V2 CPUs (12 cores) at 2.7 GHz and two Intel Xeon 
3.B | Experimental validation of the MLC simulation model
The second validation process of the in-house system was film measurement to validate the geometrical modeling of MLC. Figure 5 shows region differ between the Geant4 and the TPS. The dose profile of (a) in Fig. 6 shows about 0.1 Gy difference (about 16% of the maximum dose) at the dose fall-off region, this difference could be due to the assumption of the DLG value in TPS. Furthermore, the profiles (b) and (c) indicate that the TPS overestimates the absolute dose of abutting leakage, up to 20% of the maximum dose than the dose assessed by the Geant4. As discussed in Fig. 5 , the overestimation of the dose of the TPS in the outer penumbra region was also observed in Fig. 6 and it was about 1.5% of the maximum dose. This means that if the ratio of the LPs (short) is dominant in the complex VMAT/IMRT plan, the dose in the normal organs or tissues could be overestimated. Moreover, the dose difference map in Fig. 6 shows that the dose at the edges of the field in the y-direction differs by about 7% of the maximum dose. yellow patterns ranging from 0 to 3% dose difference and these patterns could be caused by the absolute dose difference resulting from LPs (<10mm) . The dose differences at the region indicated by the purple arrows are over 7%. We assumed that the high dose difference only near the surface of the water phantom could be caused by the difference in the dose grid sizes which for the Geant4 and the TPS were 1.17 and 1.00 mm, respectively. As the depth of the water phantom becomes deeper, it is presumed that the dose difference is reduced due to the phantom scatter. However, despite these local dose differences, the dose comparison study in the water phantom indicates almost identical dose distributions between the Geant4 and TPS. Figure 10 and Table 1 organs, respectively. The dose differences in Table 1 were calculated based on the prescribed dose. The 6 MV photon beam was delivered to the isocenter with 178 gantry angles in two opposite directions. The patient dose distributions and the two leaf-ends distance maps for the patient case in which the two beams are rotated 360 degrees in opposite directions are illustrated in Fig. 11 . Beam 2 has a larger ratio of LPs (short) than beam 1. In the map of beam 2, the ratio of LPs (short) at control points between 1 and 80 is higher than that from 81 to 178. Since the gantry rotates about 2 degrees for a control point, the total rotation angle can be assumed as 160
3.C.2 | Patient case
degrees from the first to the 80th control point. In the dose difference maps, green and blue contours indicate higher dose of TPS than that of Geant4 and especially the higher dose of TPS is noticed with the fan-shaped distribution (pink dotted line) on the right side of the XY-plane. We observed a relationship between the higher dose distributions of TPS and the distributions of LPs (short) . Because the pancreas was placed in the region of higher TPS dose, there was 3% difference of D 2% . Moreover, the differences of four PTV dosevolumetric parameters between Geant4 and TPS were about 1% or less, whereas the relative differences of the GTV (smaller volume than PTV) parameters were as high as 2.2%. We assumed that if a volume of organ or tissue of interest is very small, the dose-volumetric parameters of corresponding organ or tissue could be sensitive to the local dose differences caused by the LPs (short) .
| CONCLUSION
In this study we developed a Geant4-based independent patient dose validation system including a finely modeled MLC and automated DICOM-RT interface. The developed system was validated by three processes: MC commissioning of the modeled linac, experimental validation of the modeled MLC, and dose comparison in water between the commercial TPS and Geant4. Finally, the patient dose distribution calculated by the TPS for an abdomen case of the VMAT plan was evaluated using developed MC system.
As a result of the validation, it was confirmed that the in-house MC system was able to accurately evaluate the patient dose sufficiently. However, we found that the rounded leaf end of MLC could cause the dose difference compared to the TPS in the case of LPs (<10mm) . Da Rosa et al. 45 investigated the influence of lung heterogeneity on dose distribution in a soft tissue phantom. They evaluated PDD curves in the phantom by comparing between the dose calculated by MC method, by TPS with four algorithms, and experimental data according to the different field size from 1 × 1 cm 2 to 10 × 10 cm 2 . 44 As the results of this study, the dose difference was increased up to about 40% in the region of lung-tissue equivalent material comparing between MC and AAA for the 1 × 1 cm 2 field due to the lateral electronic disequilibrium effect. 44 In our results, about 3% difference of the prescribed dose in the normal tissue could cause by a large ratio of LPs (<10mm) in the treatment plan, even though the patient case is not that heterogeneous case. In other words, the effect of the short leaf-ends distance in a highly heterogeneous region can result in a significant dose difference. Therefore, it is necessary to quantitatively analyze the correlation between the ratio of LPs (short) and the dose difference. In the future, several treatment plans for highly heterogeneous media (e.g., lung case, head & neck case, and dummy shield case) will be evaluated with the currently developed dose validation system. 
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